«Over the last year, digital has transformed the caregiver experience, but pharma has also been undergoing a metamorphosis in order to reach patients.

During the pandemic, life science companies were pushed to reconfigure their care in order to meet the needs of some of the most at-risk patients. MobiHealthNews sat down with the leader of pharma giant Otsuka’s Global Clinical Development on Nephrology, Dr. Charlotte Jones-Burton, to talk about innovating for rare disease, digital in clinical trials and lessons learned from past tech partnerships.»

Article written by Laura Lovett



Mobi Health News